Locally Advanced Prostate Cancer clinical trials

Explore recruiting locally advanced prostate cancer clinical trials.

Recruiting locally advanced prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase I/II Study of Neoadjuvant, Intra-arterial Administration of [177Lu]Lu-PSMA-617 in Subjects with High-risk, Localised or Locally Advanced Prostate Cancer who are Candidates for Radical Prostatectomy (LUPUS)

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

SUrGery with or without dARolutamide in high-risk and/or locally advanced prostate cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localised High-risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02)

Austria, Sweden, Spain, France, Netherlands, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment with Primary Radiation Therapy

Belgium, Czechia, Sweden, Romania, Spain, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy

Spain, Netherlands, France, Germany, Italy, Czechia +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Locally Advanced Prostate Cancer trials by city

Locally Advanced Prostate Cancer in Toronto Locally Advanced Prostate Cancer in Vancouver Locally Advanced Prostate Cancer in Montreal Locally Advanced Prostate Cancer in Calgary Locally Advanced Prostate Cancer in Edmonton Locally Advanced Prostate Cancer in Ottawa Locally Advanced Prostate Cancer in Winnipeg Locally Advanced Prostate Cancer in Quebec City Locally Advanced Prostate Cancer in Hamilton Locally Advanced Prostate Cancer in Kitchener Locally Advanced Prostate Cancer in London Locally Advanced Prostate Cancer in Halifax Locally Advanced Prostate Cancer in New York Locally Advanced Prostate Cancer in Los Angeles Locally Advanced Prostate Cancer in Chicago Locally Advanced Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease